Company name: | Pharma Foods International Co., Ltd. |
Representative: | Mujo Kim, President |
(Securities code: 2929; Prime Market) | |
Inquiries: | Toshihiro Kawanaka, General Manager of Corporate Planning |
(Telephone: +81-75-394-8600) |
Pharma Foods International Co., Ltd. (the "Company") hereby announces that in line with the announcement made yesterday (on May 13, 2025) concerning the acquisition of own shares, it has repurchased its own shares as described below.
Reason for conducting acquisition of own shares
The share repurchase program, which considers the current valuation of our shares, is part of our broader strategy to return capital to shareholders, enhance capital efficiency, and fund equity-based compensation.
Details of acquisition
(1) | Class of shares acquired | Common shares |
(2) | Total number of shares acquired | 184,600 shares |
(3) | Acquisition costs | ¥175,370,000 |
(4) | Date of acquisition | May 14, 2025 |
(5) | Method of acquisition | Purchase through off-auction own share repurchase trading system (ToSTNeT-3) of the Tokyo Stock Exchange |
# # #
(Reference) Details of resolution concerning acquisition of own shares (released on May 13, 2025)
(1) | Class of shares to be acquired | Common shares |
(2) | Total number of shares to be acquired | 200,000 shares (maximum) |
(3) | Total amount of share acquisition costs | ¥190,000,000 (maximum) |
Note : This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.